|
1 |
Matsubara K, Kiyomoto H, Moriwaki K, Hara T, Kondo N, Shokoji T, Hitomi
H, Aki Y, Aono M, Nishiyama A, Ohmori K and Kohno M.
Leptin kinetics during peritoneal dialysis in acutely uremic rats.
Nephrology (Carlton). 9: 256-261, 2004. |
 |
2 |
Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura
Y, Nishiyama A, Okada H, Uddin MN, Nabi AHMN, Ishida Y, Inagami T and Saruta
T.
Inhibition of diabetic nephropathy by a decoy peptide corresponding to
the “handle” region for non-proteolytic activation of prorenin.
J. Clin. Invest. 114: 1128-1135, 2004. |
 |
3 |
Kimura S, Zhang G-X, Nagai Y, Miyata K, Nishiyama A, Shokoji T, Yao L,
Fan Y-Y, Rahman M, Fujisawa Y, Miyatake A and Abe Y.
Time dependent transition of tempol sensitive reduction of blood pressure
in angiotensin II induced hypertension.
J. Hypertens. 22: 2161-2168, 2004. |
 |
4 |
Hara T, Takahashi N, Kiyomoto H, Aki Y, Fujioka H, Shokoji T, Matsubara
K, Moriwaki K, Kondo N, Kiyomoto K, Hirohata M, Ishizu T, Akiyama K, Nishiyama
A, Ohmori K and Kohno M.
Reduction of oxidized low-density lipoprotein by the long-term use of vitamin
E-coated dialyzers in hemodialysis patients.
Dialysis Transplant. 33: 197-202, 2004. |
|
5 |
Kusudo K, Ishii K, Rahman M, Aki Y, Miyatake A, Kosaka H, Kimura S, Komatsu
T, Yokoyama M, Morita K, Abe Y and Nishiyama A.
Blood flow-dependent changes in intrarenal nitric oxide levels during anesthesia
with halothane or sevoflurane.
Eur. J. Pharmacol. 498: 267-273, 2004. |
 |
6 |
Fujisawa Y, Nagai Y, Miyatake A, Takei Y, Miura K, Shokoji T, Nishiyama
A, Kimura S and Abe Y.
Renal effects of a new member of adrenomedullin family, adrenomedullin
2 in rats.
Eur. J. Pharmacol.497: 75-80, 2004. |
 |
7 |
Shokoji T, Fujisawa Y, Kimura S, Rahman M, Kiyomoto H, Kohno M, Abe Y and
Nishiyama A.
Effects of local administrations of tempol and diethyldithio-carbamic on
peripheral nerve activity.
Hypertension. 44: 236-243, 2004. |
 |
8 |
Yao L, Kobori H, Rahman M, Seth DM, Shokoji T, Fan Y, Zhang G-X, Kimura
S, Abe Y and Nishiyama A.
Olmesartan improves endotheline-induced hypertension and oxidative stress
in rats.
Hypertens. Res. 27: 493-500, 2004. |
 |
9 |
Majid DSA, Nishiyama A, Jackson KE and Castillo A.
Inhibition of nitric oxide synthase enhances superoxide activity in canine
kidney.
Am. J. Physiol. Regul. Intergr. Comp. Physiol. 287: R27-R32, 2004. |
 |
10 |
Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Shokoji T, Kiyomoto H, Kimura S, Kohno M and Abe Y.
Possible contributions of reactive oxygen species and mitogen-activated
protein kinase to renal injury in aldosterone/salt-induced hypertensive
rats.
Hypertension. 43: 841-848, 2004. |
 |
11 |
Suzaki Y, Yoshizumi M, Kagami S, Nishiyama A, Ozawa Y, Kyaw M, Izawa Y, Kanematsu Y, Tsuchiya K and Tamaki T.
BMK1 is activated in glomeruli of diabetic rats and in mesangial cells
by high glucose conditions.
Kidney Int. 65: 1749-1760, 2004 |
 |
12 |
Nishiyama A, Yoshizumi M, Rahman M, Kobori H, Seth DM, Miyatake A, Zhang G-X, Yao
L, Hitomi H, Kiyomoto H, Kimura S, Tamaki T, Kohno M and Abe Y.
Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity
in Dahl salt-sensitive rats.
Kidney Int. 65: 972-981, 2004. |
 |
13 |
Rahman M, Kimura S, Nishiyama A, Hitomi H, Zhang G-X and Abe Y.
Angiotensin II stimulates superoxide production via both angiotensin AT1A and AT1B receptors in mouse aorta and heart.
Eur. J. Pharmacol. 485: 243-249, 2004. |
 |
14 |
Kobori H and Nishiyama A.
Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive
rats.
Biochem. Biophys. Res. Commun. 315: 746-750, 2004. |
 |
15 |
Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, Fukunaga M, Tamaki
T, Kiyomoto H, Kohno M, Shokoji T, Kimura S and Abe Y.
The SOD mimetic tempol ameliorates glomerular injury and reduces MAPK activity
in Dahl salt-sensitive rats.
J. Am. Soc. Nephrol. 15: 306-315, 2004. |
 |
16 |
Zhang G-X, Kimura S, Nishiyama A, Shokoji T, Rahman M and Abe Y.
ROS during the acute phase of angiotensin II hypertension participates
in cardiovascular MAPK activation but not vasoconstriction.
Hypertension. 43: 117-124, 2004. |
 |
17 |
Nishiyama A, Rahman M and Inscho EW.
Role of interstitial ATP and adenosine in the regulation of renal hemodynamics
and microvascular function.
Hypertens. Res. 27: 791-804, 2004. |
 |
18 |
Navar LG and Nishiyama A.
Why are angiotensin concentrations so high in the kidney?
Curr. Opin. Nephrol. Hypertens. 13: 107-115, 2004. |
 |
19 |
Ichihara A, Kobori H, Nishiyama A and Navar LG.
Renal renin-angiotensin system. In: Kidney and blood pressure regulation.
Contrib. Nephrol. 143. Edited by H. Suzuki and T. Saruta. pp. 117-130,
2004. Karger. |
 |
20 |
Kimura S, Zhang GX, Abe Y.
Mulfunction of Vascular Control in Lifestyle-Related Disease: Oxidative
stress of angiotensin II-induced hypertension: Mitogen-activated protein
kinases and blood pressure regulation.
Jpn J Pharmacol. (J Pharmacol Sci. に改称)_96: 406-410,2004. |
 |
21 |
M Rahman, A Nishiyama, T Yamamoto, T Shokoji, S Kimura, Y Abe.
Tubuloglomerular feedback (TGF) response in Dahl salt-sensitive hypertensive rats.
JOURNAL OF PHARMACOLOGICAL SCIENCES 94 265P - 265P 2004. |
 |
22 |
H Kurata, T Fujii, T Katayama, H Tsutsui, M Takaoka, Y Kiso, Y Fujisawa, T Shokoji, A Nishiyama, Y Abe, Y Matsumura.
Preventive effect of L-carnosine on ischemic acute renal failure in rats.
JOURNAL OF PHARMACOLOGICAL SCIENCES 94 113P - 113P 2004. |
 |
23 |
H Kobori, A Nishiyama.
Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 315(3) 746 - 750 2004. |
 |